Calendrier des promotions Takeda Pharmaceutical Company Limited
À propos de l'entreprise Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited занимается исследованиями, разработками, производством, маркетингом и лицензированием фармацевтической продукции по всему миру. Предлагает фармацевтические продукты в области гастроэнтерологии; онкология; неврология; и редкие заболевания, такие как редкие метаболические и гематологические и наследственный ангионевротический отек, а также терапия и вакцины на основе плазмы. plus de détailsGrade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 1.55 | 8 |
| P/BV | 0.909 | 9 |
| P/E | 45.9 | 3 |
Efficacité
| Nom | Signification | Grade |
| ROA | 0.9913 | 1 |
| ROE | 2.11 | 1 |
| ROIC | 5.63 | 2 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 6.66 | 10 |
| DSI | 0.9286 | 9.29 |
| Croissance moyenne du dividende | 1.27 | 2.11 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 5.54 | 0 |
| Debt/Ratio | 0.3206 | 10 |
| Debt/Equity | 0.666 | 9 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 29.55 | 4 |
| Rentabilité Ebitda, % | 30.18 | 5 |
| Rentabilité EPS, % | 222.73 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 4 375 ¥ | 0 ¥ | 0 ¥ | -0.78 % | 0 % | 0 % |
| common.calendar.number_days.7d | 4 336 ¥ | 4 336 ¥ | 4 375 ¥ | 0.12 % | 0 % | 0 % |
| common.calendar.number_days.30d | 4 165 ¥ | 4 078 ¥ | 4 375 ¥ | 4.23 % | 0 % | 0 % |
| common.calendar.number_days.90d | 4 120 ¥ | 3 933 ¥ | 4 566 ¥ | 5.36 % | 0 % | 0 % |
| common.calendar.number_days.180d | 4 095 ¥ | 3 933 ¥ | 4 566 ¥ | 6.01 % | 0 % | 0 % |
| common.calendar.number_days.1y | 4 340 ¥ | 3 903 ¥ | 4 566 ¥ | 0.02 % | 0 % | 0 % |
| common.calendar.number_days.3y | 3 850 ¥ | 3 552 ¥ | 4 860 ¥ | 12.75 % | 0 % | 0 % |
| common.calendar.number_days.5y | 6 065 ¥ | 3 070 ¥ | 4 860 ¥ | -28.43 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 ¥ | 2 918.5 ¥ | 6 644 ¥ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 4 151 ¥ | 3 933 ¥ | 4 566 ¥ | 4.58 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
| ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
| First Trust Developed International Equity Select ETF | 1.98 | 22.94 | 0.65 |
| AAM S&P Developed Markets High Dividend Value ETF | 1.81037 | 2.67 | 0.39 |
| Global Beta Smart Income ETF | 1.42876 | -8.5 | 0.45 |
| Direxion Daily Japan Bull 3x Shares | 1.03055 | 6.34 | 0.45 |
| VictoryShares International High Div Volatility Wtd ETF | 1.02628 | 0.7476 | 0.45 |
| IQ 500 International ETF | 0.24739 | -4.21 | 0.25 |
| VictoryShares Developed Enhanced Volatility Wtd ETF | 0.23829 | 0.8332 | 0.51 |
| 1,11 | 2,97 | 0,45 |
|---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Christophe Weber | President, CEO & Representative Director | 572M | 1966 (59 années) |
| Mr. Haruhiko Hirate | Member of Management Board | N/A | 1957 (68 années) |
| Norimasa Takeda | Chief Accounting Officer & Corporate Controller | N/A | |
| Mr. Iwaaki Taniguchi | Senior Vice President of Corporate Finance & Controlling Department | N/A | |
| Mr. Gabriele Ricci | Chief Data & Technology Officer | N/A | 1978 (47 années) |
| Mr. Christopher David O'Reilly | Global Head of Investor Relations & Global Finance | N/A | |
| Mr. Salvatore Alesci M.D., Ph.D. | Member of Management Board and Head of R&D Global Science & Biomedical Policy | N/A | 1975 (50 années) |
| Mr. Yoshihiro Nakagawa | Global General Counsel | N/A | 1960 (65 années) |
| Ms. Mwana Lugogo | Chief Ethics & Compliance Officer | N/A | 1970 (55 années) |
| Mr. Ken Araki | Vice President of Global Licensing & Business Development Department | N/A |
Informations sur l'entreprise
Adresse: Japan, Tokyo -, 1-1. Nihonbashi-Honcho 2-chome - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.takeda.com
Site web: https://www.takeda.com
